Our brain is a central system tower that controls the whole body. It is the most important part of thinking and moving and deciding what to do. Han Hyung-seop, CEO of HHS Co, Ltd, is a company that identifies biorhythms with these brain waves and uses artificial intelligence as data collected. He is a bioengineering major and has done research specifically on data signals. Therefore, he developed a helmet-type device by intensively studying the signature of data, which is the core of artificial intelligence solutions, in cognitive biorhythm.
The Tencent Institute of Artificial Intelligence in China has launched an artificial intelligence model that detects human movements and detects Parkinson’s disease.The evaluation process is simple. When a person makes a series of actions in front of a camera, artificial intelligence analyzes and diagnoses through image identification technology. It is said that it is trying to release an identification model that helps rehabilitate patients with cerebral palsy in the future and a model that analyzes the motor nerves of older people.
As such, multinational and large companies are already actively researching and developing various milk powders using artificial intelligence, especially in healthcare. However, the resistance of medical staff who suspect accurate analysis and diagnosis is also fierce, appealing to and approaching the public under the names of smart care, non-face-to-face care and video care. It is thought that proper cooperation and communication in both areas can achieve the most appropriate diagnostic analysis solution. In the end, the idea is that to accurately analyze and diagnose the collected data, we must provide a lot of reference data to artificial intelligence and operate big data well.
HHS CEO Han demonstrating his product
Currently, the world has access and research using artificial intelligence in many fields such as industrial groups and healthcare. Therefore, HHS’s development solutions are also worthy of attention. However, how to be linked and what areas to be developed should eventually be collected with data on biorhythms through the brain, and artificial intelligence solutions should be useful. Toyota, DataScope, Maxell, Carecom, and others, which are leading Japanese companies, are already interested in developing businesses that use solutions with this company through contracts such as NDA (Non Disclosure Agreement). What we need to note about this is that this company’s development capability has reached a significant level.
SAM KIM
Asia Journal
HHS
▲ HHS Co., Ltd.
▲ CEO : Hyung-seob Han
▲ Brand : HHS, PINYFINY
▲ +82-10-6733-5112
